Further study has demonstrated that it promotes the tumorigenic capacity of HCC stem cells through binding to GRP78, leading to the hyperactivation of Akt/β-catenin signaling (Yu et al, 2023). This evidence concerns the gene HSPA5 and hepatocellular carcinoma.